A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: Reversal by a D1 receptor agonist injected into the medial prefrontal cortex

Neuropsychopharmacology

Volumn 32, Issue 5, 2007, Pages 1122-1132

  Fletcher, Paul J ^a,b   Tenn, Catherine C ^a,c   Sinyard, Judy ^a   Rizos, Zoë ^a   Kapur, Shitij ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

Author keywords

Amphetamine; Dopamine D1 receptor; Prefrontal cortex; Schizophrenia; Visual attention

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DEXAMPHETAMINE;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; ATTENTION DEFICIT DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG EXPOSURE; DRUG POTENTIATION; DRUG SENSITIZATION; DRUG WITHDRAWAL; ERROR; MALE; NONHUMAN; PHOTOSTIMULATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RESPONSE TIME; SCHIZOPHRENIA; TASK PERFORMANCE; VISION;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; AMPHETAMINE; ANIMALS; ATTENTION; COGNITION; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NEUROPSYCHOLOGICAL TESTS; PHOTIC STIMULATION; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, DOPAMINE D1; SUBSTANCE WITHDRAWAL SYNDROME; VISUAL PERCEPTION;

EID: 34247327039     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301221     Document Type: Article

References (72)

1. Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M et al (1998). Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 155: 761-767.
2. Ben-Shahar O, Ahmed SH, Koob GF, Ettenberg A (2004). The transition from controlled to compulsive drug use is associated with a loss of sensitization. Brain Res 995: 46-54.
3. Birrell JM, Brown VJ (2000). Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 20: 4320-4324.
4. Briggs CA, Pollock NJ, Frail DE, Paxson CL, Rakowski RF, Kang CH et al (1991). Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393. Br J Pharmacol 104: 1038-1044.
5. Castner SA, Goldman-Rakic PS, Williams GV (2004). Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia. Psychopharmacology (Berlin) 174: 111-125.
6. Castner SA, Vosler PS, Goldman-Rakic PS (2005). Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex. Biol Psychiatry 57: 743-751.
7. Chudasama Y, Passetti F, Rhodes SE, Lopian D, Desai A, Robbins TW (2003). Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity. Behav Brain Res 146: 105-119.
8. Cole BJ, Robbins TW (1987). Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task: new evidence for central dopaminergic-noradrenergic interactions. Psychopharmacology (Berlin) 91: 458-466.
9. Cole BJ, Robbins TW (1989). Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav Brain Res 33: 165-179.
10. Crombag HS, Gorny G, Li Y, Kolb B, Robinson TE (2005). Opposite effects of amphetamine self-administration experience on dendritic spines in the medial and orbital prefrontal cortex. Cereb Cortex 15: 341-348.
11. Dalley JW, Theobald DE, Berry D, Milstein JA, Laane K, Everitt BJ et al (2005). Cognitive sequelae of intravenous amphetamine self-administration in rats: evidence for selective effects on attentional performance. Neuropsychopharmacology 30: 525-537.
12. Deller T, Sarter M (1998). Effects of repeated administration of amphetamine on behavioral vigilance: evidence for 'sensitized' attentional impairments. Psychopharmacology (Berlin) 137: 410-414.
13. Ellenbroek BA, Knobbout DA, Cools AR (1997). The role of mesolimbic and nigrostriatal dopamine in latent inhibition as measured with the conditioned taste aversion paradigm. Psychopharmacology (Berlin) 129: 112-120.
14. Feldpausch DL, Needham LM, Stone MP, Althaus JS, Yamamoto BK, Svensson KA et al (1998). The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations. J Pharmacol Exp Ther 286: 497-508.
15. Fletcher PJ, Tenn CC, Rizos Z, Lovic V, Kapur S (2005). Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex. Psychopharmacology (Berln) 183: 190-200.
16. Goldman-Rakic PS (1995). Cellular basis of working memory. Neuron 14: 477-485.
17. Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ, Williams GV (2004). Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berlin) 174: 3-16.
18. Granon S, Passetti F, Thomas KL, Dalley JW, Everitt BJ, Robbins TW (2000). Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 20: 1208-1215.
19. Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S et al (2004). Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry 56: 301-307.
20. Hedou G, Homberg J, Feldon J, Heidbreder CA (2001). Expression of sensitization to amphetamine and dynamics of dopamine neurotransmission in different laminae of the rat medial prefrontal cortex. Neuropharmacology 40: 366-382.
21. Higgins GA, Enderlin M, Haman M, Fletcher PJ (2003). The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism. Psychopharmacology (Berlin) 170: 309-319.
22. Howes OD, McDonald C, Cannon M, Arseneault L, Boydell J, Murray RM (2004). Pathways to schizophrenia: the impact of environmental factors. Int J Neuropsychopharmacol 7(Suppl 1): S7-S13.
23. Jeanblanc J, Hoeltzel A, Louilot A (2002). Dissociation in the involvement of dopaminergic neurons innervating the core and shell subregions of the nucleus accumbens in latent inhibition and affective perception. Neuroscience 111: 315-323.
24. Jentsch JD, Olausson P, De La Garza II R, Taylor JR (2002). Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys. Neuropsychopharmacology 26: 183-190.
25. Jones MW (2002). A comparative review of rodent prefrontal cortex and working memory. Curr Mol Med 2: 639-647.
26. Joseph MH, Peters SL, Moran PM, Grigoryan GA, Young AM, Gray JA (2000). Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning. Neuroscience 101: 921-930.
27. Keefe RSE (2001). Neurocognition. In Breier A, Tran PV, Herrera JM, Tollefson GD, Bymaster FP (eds). Current Issues in the Psychopharmacology of Schizophrenia. Lippincott, Williams & Wilkins: Philadelphia. pp 192-205.
28. Kodsi MH, Swerdlow NR (1994). Quinolinic acid lesions of the ventral striatum reduce sensorimotor gating of acoustic startle in rats. Brain Res 643: 59-65.
29. Laruelle M (2000). The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Brain Res Rev 31: 371-384.
30. Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R (1999). Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 46: 56-72.
31. Lehmann O, Grottick AJ, Cassel JC, Higgins GA (2003). A double dissociation between serial reaction time and radial maze performance in rats subjected to 192 IgG-saporin lesions of the nucleus basalis and/or the septal region. Eur J Neurosci 18: 651-666.
32. Lieberman JA, Kane JM, Alvir J (1987). Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology (Berlin) 91: 415-433.
33. Lieberman JA, Sheitman BB, Kinon BJ (1997). Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 17: 205-229.
34. Lu W, Monteggia LM, Wolf ME (1999). Withdrawal from repeated amphetamine administration reduces NMDAR1 expression in the rat substantia nigra, nucleus accumbens and medial prefrontal cortex. Eur J Neurosci 11: 3167-3177.
35. Lu W, Wolf ME (1999). Repeated amphetamine administration alters AMPA receptor subunit expression in rat nucleus accumbens and medial prefrontal cortex. Synapse 32: 119-131.
36. Martinez V, Parikh V, Sarter M (2005). Sensitized attentional performance and Fos-immunoreactive cholinergic neurons in the basal forebrain of amphetamine-pretreated rats. Biol Psychiatry 57: 1138-1146.
37. McAlonan K, Brown VJ (2003). Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. Behav Brain Res 146: 97-103.
38. Muir JL, Everitt BJ, Robbins TW (1994). AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J Neurosci 14: 2313-2326.
39. Muir JL, Everitt BJ, Robbins TW (1996). The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cereb Cortex 6: 470-481.
40. Muir JL, Page KJ, Sirinathsinghji DJ, Robbins TW, Everitt BJ (1993). Excitotoxic lesions of basal forebrain cholinergic neurons: effects on learning, memory and attention. Behav Brain Res 57: 123-131.
41. Murphy CA, Fend M, Russig H, Feldon J (2001). Latent inhibition, but not prepulse inhibition, is reduced during withdrawal from an escalating dosage schedule of amphetamine. Behav Neurosci 115: 1247-1256.
42. Nelson LR, Ellison G (1978). Enhanced stereotypies after repeated injections but not continuous amphetamines. Neuropharmacology 17: 1081-1084.
43. Neumeyer JL, Kula NS, Bergman J, Baldessarini RJ (2003). Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines. Eur J Pharmacol 474: 137-140.
44. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK (2004). Identification of separable cognitive factors in schizophrenia. Schizophr Res 72: 29-39.
45. Nuechterlein KH, Robbins TW, Einat H (2005). Distinguishing separable domains of cognition in human and animal studies: what separations are optimal for targeting interventions? A summary of recommendations from breakout group 2 at the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophr Bull 31: 870-874.
46. Passetti F, Chudasama Y, Robbins TW (2002). The frontal cortex of the rat and visual attentional performance: dissociable functions of distinct medial prefrontal subregions. Cereb Cortex 12: 1254-1268.
47. Passetti F, Dalley JW, Robbins TW (2003). Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five-choice reaction time task. Psychopharmacology (Berlin) 165: 136-145.
48. Paulson PE, Robinson TE (1995). Amphetamine-induced timedependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse 19: 56-65.
49. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates, 4th edn. Academic Press: Sydney.
50. Peterson JD, Wolf ME, White FJ (2000). Altered responsiveness of medial prefrontal cortex neurons to glutamate and dopamine after withdrawal from repeated amphetamine treatment. Synapse 36: 342-344.
51. Peterson JD, Wolf ME, White FJ (2006). Repeated amphetamine administration decreases D1 dopamine receptor-mediated inhibition of voltage-gated sodium currents in the prefrontal cortex. J Neurosci 26: 3164-3168.
52. Post RM (1980). Intermittent vs continuous stimulation: effect of time interval on the development of sensitization or tolerance. Life Sci 26: 1275-1282.
53. Pratt WE, Mizumori SJ (2001). Neurons in rat medial prefrontal cortex show anticipatory rate changes to predictable differential rewards in a spatial memory task. Behav Brain Res 123: 165-183.
54. Robbins TW (2002). The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berlin) 163: 362-380.
55. Robinson TE (1984). Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology (Berlin) 84: 466-475.
56. Robinson TE, Becker JB (1986). Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396: 157-198.
57. Robinson TE, Jurson PA, Bennett JA, Bentgen KM (1988). Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res 462: 211-222.
58. Robinson TE, Kolb B (1997). Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17: 8491-8497.
59. Russig H, Kovacevic A, Murphy CA, Feldon J (2003). Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion. Psychopharmacology (Berlin) 170: 263-270.
60. Russig H, Murphy CA, Feldon J (2002). Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal. Neuropsychopharmacology 26: 765-777.
61. Sato M, Numachi Y, Hamamura T (1992). Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 18: 115-122.
62. Schoenbaum G, Saddoris MP, Ramus SJ, Shaham Y, Setlow B (2004). Cocaine-experienced rats exhibit learning deficits in a task sensitive to orbitofrontal cortex lesions. Eur J Neurosci 19: 1997-2002.
63. Sirvio J, Mazurkiewicz M, Haapalinna A, Riekkinen Jr P, Lahtinen H, Riekkinen Sr PJ (1994). The effects of selective alpha-2 adrenergic agents on the performance of rats in a 5-choice serial reaction time task. Brain Res Bull 35: 451-455.
64. Solomon PR, Staton DM (1982). Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus. Biol Psychiatry 17: 743-756.
65. Sorg BA, Davidson DL, Kalivas PW, Prasad BM (1997). Repeated daily cocaine alters subsequent cocaine-induced increase of extracellular dopamine in the medial prefrontal cortex. J Pharmacol Exp Ther 281: 54-61.
66. Swerdlow NR, Mansbach RS, Geyer MA, Pulvirenti L, Koob GF, Braff DL (1990). Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology (Berlin) 100: 413-416.
67. Tenn CC, Fletcher PJ, Kapur S (2003). Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia. Schizophr Res 64: 103-114.
68. Tenn CC, Kapur S, Fletcher PJ (2005). Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition. Psychopharmacology (Berlin) 183: 190-200.
69. Ujike H (2002). Stimulant-induced psychosis and schizophrenia: the role of sensitization. Curr Psychiatry Rep 4: 177-184.
70. Vanderschuren LJ, Kalivas PW (2000). Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berlin) 151: 99-120.
71. Vanderschuren LJ, Schmidt ED, De Vries TJ, Van Moorsel CA, Tilders FJ, Schoffelmeer AN (1999). A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats. J Neurosci 19: 9579-9586.
72. Wan FJ, Swerdlow NR (1996). Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions. Brain Res 722: 168-176.